- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Humanised IgG1 monoclonal antibody against the receptor-bind
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
Humanised IgG1 monoclonal antibody against the receptor-binding site of human placental growth factor
| EU orphan designation number: | EU/3/16/1819
|
| Active ingredient: | Humanised IgG1 monoclonal antibody against the receptor-binding site of human placental growth factor |
| Indication: | Treatment of medulloblastoma |
| Sponsor: | Oncurious NV
Gaston Geenslaan 1, B-3001 Leuven, Belgïe |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 16/01/2017 | Orphan designation | EMA/OD/240/16 | (2017)223 of 12/01/2017 |
CONTACT
EU links
Directorate General Health & Consumers